A recent review of the human papillomavirus (HPV) vaccine is has found that in the 10 years since its original release, the infection rate of HPV has been lowered by up to 90 percent in countries with high levels of immunisation. The review found that with more than 187 million doses of the vaccine administered in 130 countries around the world, the number of HPV infections fell by up to 90 percent in some areas, with similar decreases in genital warts and cervical abnormalities also being reported. “Reductions in HPV infections as well as reductions in the prevalence of HPV 6/11/16/18-related diseases, as noted by decreases in Pap abnormalities, cervical pre-cancers, and genital warts, were detected within four years after vaccine introduction,” said lead researcher Suzanne Garland, from the Royal Woman’s Hospital in Australia. HPV is a DNA virus that spreads through sexual contact. Before this vaccine, having one of more of these...
🔒 Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!




